Ligand binding assays in the 21st Century laboratory: platforms.
作者信息
Spriggs Franklin P, Zhong Zhandong Don, Safavi Afshin, Jani Darshana, Dontha Narasaiah, Kant Anita, Ly Jenny, Brilando Lia, Österlund Karolina, Rouleau Nathalie, Fischer Saloumeh Kadkhodayan, Boissonneault Martin, Ray Chad
机构信息
Department of Pharmacokinetics, Dynamics, and Metabolism, Pfizer, Inc., Andover, Massachusetts 01810, USA.
出版信息
AAPS J. 2012 Mar;14(1):113-8. doi: 10.1208/s12248-012-9321-1.
Abstract
摘要
相似文献
1
Ligand binding assays in the 21st Century laboratory: platforms.21世纪实验室中的配体结合分析：平台
AAPS J. 2012 Mar;14(1):113-8. doi: 10.1208/s12248-012-9321-1.
2
Ligand binding assays in the 21st Century laboratory: automation.21世纪实验室中的配体结合分析：自动化
AAPS J. 2012 Mar;14(1):142-53. doi: 10.1208/s12248-012-9323-z.
3
Ligand-binding assays in the 21st Century laboratory: recommendations for an automated data interchange process.21世纪实验室中的配体结合分析：自动化数据交换流程的建议
AAPS J. 2012 Mar;14(1):105-12. doi: 10.1208/s12248-011-9319-0. Epub 2012 Jan 14.
4
Development of novel IVD assays: a manufacturer's perspective.新型体外诊断检测方法的开发：制造商视角
Scand J Clin Lab Invest Suppl. 2010;242:23-6. doi: 10.3109/00365513.2010.493361.
5
Screening for drug discovery: the leading question.药物发现的筛选：首要问题。
Nature. 2002 Jul 25;418(6896):453-9. doi: 10.1038/418453a.
6
'Organs-on-chips' go mainstream.“芯片器官”成为主流。
Nature. 2015 Jul 16;523(7560):266. doi: 10.1038/523266a.
7
The evolution of guidelines for the validation of flow cytometric methods.流式细胞术方法验证指南的演变
Int J Lab Hematol. 2015 May;37 Suppl 1:3-10. doi: 10.1111/ijlh.12344.
8
Genesis IV--Fourth London Biotechnology Conference.《创世纪IV——第四届伦敦生物技术会议》
IDrugs. 2005 Jan;8(1):34-6.
9
Industry perspectives on the development of biologics.生物制品发展的行业观点。
PM R. 2011 Jun;3(6 Suppl 1):S132-5. doi: 10.1016/j.pmrj.2011.05.006.
10
New horizons in pharmaceutical biotechnology by melding biology and engineering.通过融合生物学与工程学实现制药生物技术的新突破。
Curr Opin Biotechnol. 2013 Dec;24(6):1069-71. doi: 10.1016/j.copbio.2013.10.001. Epub 2013 Oct 23.
引用本文的文献
1
Recent Advances in Bioanalytical Methods for Quantification and Pharmacokinetic Analyses of Antibody-Drug Conjugates.抗体药物偶联物定量及药代动力学分析的生物分析方法最新进展
AAPS J. 2025 Sep 4;27(6):138. doi: 10.1208/s12248-025-01115-9.
2
A fully-automated, six-plex single molecule immunoassay for measuring cytokines in blood.一种用于测量血液中细胞因子的全自动六联单分子免疫测定法。
J Immunol Methods. 2015 Sep;424:20-7. doi: 10.1016/j.jim.2015.04.017. Epub 2015 May 7.
3
A white paper--consensus and recommendations of a global harmonization team on assessing the impact of immunogenicity on pharmacokinetic measurements.一份白皮书——评估免疫原性对药代动力学测量影响的全球协调团队的共识和建议。
AAPS J. 2014 May;16(3):488-98. doi: 10.1208/s12248-014-9582-y. Epub 2014 Mar 29.
4
Ligand binding assays in the 21st century laboratory-a call for change.21世纪实验室中的配体结合分析——变革的呼声。
AAPS J. 2012 Sep;14(3):377-9. doi: 10.1208/s12248-012-9351-8. Epub 2012 Apr 3.
本文引用的文献
1
Overview of high-throughput screening.高通量筛选概述。
Curr Protoc Pharmacol. 2009 Mar;Chapter 9:Unit 9.4. doi: 10.1002/0471141755.ph0904s44.
2
Comparison of four distinct detection platforms using multiple ligand binding assay formats.采用多种配体结合分析方法的四种不同检测平台的比较。
J Immunol Methods. 2011 Aug 31;371(1-2):106-13. doi: 10.1016/j.jim.2011.06.020. Epub 2011 Jul 3.
3
Solution ELISA as a platform of choice for development of robust, drug tolerant immunogenicity assays in support of drug development.解决方案 ELISA 作为一个平台，选择开发稳健、耐药性免疫原性检测方法，以支持药物开发。
J Immunol Methods. 2011 Feb 28;365(1-2):38-49. doi: 10.1016/j.jim.2010.11.011. Epub 2010 Dec 1.
4
Ligand-binding assays: risk of using a platform supported by a single vendor.配体结合分析：使用单一供应商支持的平台的风险。
Bioanalysis. 2009 Jun;1(3):629-36. doi: 10.4155/bio.09.46.
5
Detection of low-affinity anti-drug antibodies and improved drug tolerance in immunogenicity testing by Octet(®) biolayer interferometry.利用 Octet(®) 生物层干涉技术检测低亲和力抗药物抗体和改善免疫原性试验中的药物耐受性。
J Pharm Biomed Anal. 2011 Jan 25;54(2):286-94. doi: 10.1016/j.jpba.2010.08.022. Epub 2010 Sep 24.
6
Comparison of the NIDS® rapid assay with ELISA methods in immunogenicity testing of two biotherapeutics.在两种生物治疗药物的免疫原性测试中，NIDS®快速检测法与酶联免疫吸附测定法的比较。
J Pharmacol Toxicol Methods. 2011 Mar-Apr;63(2):150-9. doi: 10.1016/j.vascn.2010.09.003. Epub 2010 Sep 22.
7
A strategy for improving comparability across sites for ligand binding assays measuring therapeutic proteins.提高测量治疗性蛋白的配体结合分析试验中各试验点间可比性的策略。
J Pharm Biomed Anal. 2010 Nov 2;53(3):729-34. doi: 10.1016/j.jpba.2010.04.022. Epub 2010 Apr 24.
8
Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products.用于检测宿主针对生物技术产品抗体的免疫分析验证建议。
J Pharm Biomed Anal. 2008 Dec 15;48(5):1267-81. doi: 10.1016/j.jpba.2008.09.020. Epub 2008 Sep 19.
9
Improvement of drug tolerance in immunogenicity testing by acid treatment on Biacore.通过Biacore上的酸处理提高免疫原性测试中的药物耐受性
J Immunol Methods. 2008 May 20;334(1-2):29-36. doi: 10.1016/j.jim.2008.01.010. Epub 2008 Feb 14.
10
Detection of high- and low-affinity antibodies against a human monoclonal antibody using various technology platforms.使用各种技术平台检测针对人单克隆抗体的高亲和力和低亲和力抗体。
Assay Drug Dev Technol. 2007 Oct;5(5):655-62. doi: 10.1089/adt.2007.089.
Zotero 插件